Percheron Therapeutics Limited (ASX:PER)
Australia · Delayed Price · Currency is AUD 0.0090
-0.0010 (-10.00%)
Aug 14, 2025, 3:28 PM AEST
Envestnet Market Cap
Percheron Therapeutics has a market cap or net worth of 10.33 million as of August 14, 2025. Its market cap has decreased by -85.68% in one year.
Market Cap
10.33M
Enterprise Value
-6.99M
Revenue
1.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since December 20, 2001, Percheron Therapeutics's market cap has decreased from 26.10M to 10.33M, a decrease of -60.42%. That is a compound annual growth rate of -3.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 10.87M | 42.86% |
| Dec 31, 2024 | 7.61M | -85.69% |
| Dec 29, 2023 | 53.19M | -18.04% |
| Dec 30, 2022 | 64.90M | -50.23% |
| Dec 31, 2021 | 130.40M | 74.75% |
| Dec 31, 2020 | 74.62M | 78.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 127.74B |
| Pro Medicus | 31.84B |
| Cochlear | 20.37B |
| Sonic Healthcare | 13.62B |
| Ramsay Health Care | 8.91B |
| Telix Pharmaceuticals | 5.72B |
| Ansell | 4.52B |
| Mesoblast | 2.93B |